Clinical features and management of Merkel Cell Carcinoma

Journal of the Pakistan Medical Association

Volumn 57, Issue 7, 2007, Pages 368-371

  Abbasi, Ahmed Nadeem ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; OCTREOTIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; EXCISION; HUMAN; MERKEL CELL TUMOR; OVERALL SURVIVAL; PATIENT CARE; PATIENT INFORMATION; PATIENT PARTICIPATION; RADIATION INJURY; RADIOSENSITIVITY; REVIEW; SURVIVAL RATE; SURVIVAL TIME; ADJUVANT THERAPY; NEUROENDOCRINE TUMOR; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, MERKEL CELL; HUMANS; NEUROENDOCRINE TUMORS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL; TREATMENT OUTCOME;

EID: 35748942575     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Lewis KG, Weinstock MA, Weaver AL, Otley CC.Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatology. 2006 142:693-700.
2. Toker C. Trabecular carcinoma of skin. Arch Dermatol 1972. 105; 107-10.
3. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20: 588-98.
4. Akhtar S, Oza KK, Wright J: Merkel cell carcinoma ; report of 10 cases and review of the literature. J Am Acad Dermotol 2000;43: 755-67.
5. Van Gele M,Kaghad M,Leonard JH,Van Roy N,Naeyaert JM,Geerts ML,et al.Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000;82: 823-6.
6. Price P, Sikora K. Treatment of Cancer,4th Edition. Arnold Publishers London 2002; pp 1213-9.
7. Yom SS, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:761-8.
8. Leech SN, Kolar AJ, Barrett PD,Sinclair SA,Leonard N. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and TTF-1. J Clin Pathol 2001;54;727-9.
9. Koljonen V, Tukiainen E, Haglund C, Bohling T. Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma.Anticancer Res 2006;26:2209-12.
10. Tope WD, Sangueza OP. Merkel cell carcinoma. Histopathology, immunocyto chemistry and cytogenetic analysis. J Dermatol Surg Oncol 1994;20:653-4.
11. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK . Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126: 1514-9.
12. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31: 325-31.
13. Clifford KS, Parez CA,Brady LW.Radiation Oncology,management decisions.2nd Edition 2001,Lippincot Williams & Wilkins Publishers, Philadelphia, Chapter 13 pp 116.
14. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH. A metanalysis of the prognostic significance of SLN status in Merkel cell carcinoma. Dermatol Surg 2002;28;113-7.
15. Nathu RM, Mendenhall WM, Persons JT. Merkel cell carcinoma of the skin. Radiat Oncol Investig 1998;6:233-9.
16. Voog E, Biron P, Martin JP, BlayJY. Chemotherapy for patient with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85:2589-95.
17. Solan MJ, Brady LW, Binnick SA in Parez CA, Brady LW editors, Principles & Practice of Radiation Oncology,3rd Edition; Philadelphia: Lippincot Raven Publishers; pp 723.
18. Swann MH, Yoon J. Merkel cell carcinoma .Semin Oncol. 2007; 34:51-6.
19. Durand JM., Weiller C, Richard MA, Portal I, Mongin M. Treatment of Merkel cell tumor with interferon-Alpha-20. Br J Dermatol 1991;124:509.
20. Ito Y, Kawamura K, Miura T, Ueda K, Onodera H, Takahashi H . Merkel cell carcinoma. A successful treatment with tumor necrosis factor. Arch Dermatol 1989; 125:1093-5.
21. Sandel HD, Day T, Richardson MS, Scarlett M, Gutman KA. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope. 2006;116:791-5.
22. Ortin-Perez J, van Rijk MC, Valdes-Olmos RA, Vidal-Sicart S, Nieweg OE, Vilalta A et al. Pons F. Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol 2007;33:119-22.
23. Senchenkov A, Barnes SA, Moran SL. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities. J Surg Oncol 2007;95:229-34.